Giamarellos-Bourboulis, Evangelos J. http://orcid.org/0000-0003-4713-3911
Kotsaki, Antigone
Routsi, Christina
Graziano, Elena
Righi, Elda
Bassetti, Matteo
Funding for this research was provided by:
Merck Hellas (70/3/11471)
Article History
Received: 8 July 2018
Accepted: 30 July 2018
First Online: 6 August 2018
Compliance with ethical standards
:
: EJ Giamarellos-Bourboulis has received honoraria (paid to the University of Athens) from AbbVie USA, Abbott CH, Biotest Germany, Brahms GmbH, InflaRx GmbH, the Medicines Company, MSD Greece, and XBiotech Inc. He has received independent educational grants from AbbVie, Abbott, Astellas Pharma, AxisShield, bioMérieux Inc., InflaRx GmbH, the Medicines Company, and XBiotech Inc. He has received funding from the FrameWork 7 program HemoSpec and from the Horizon2020 Marie-Curie project European Sepsis Academy (granted to the National and Kapodistrian University of Athens).M Bassetti serves on scientific advisory boards for Angelini, AstraZeneca, Bayer, Cubist, Pfizer, Menarini, MSD, Nabriva, Paratek, Roche, Shionogi, Tetraphase, The Medicine Company, and Astellas Pharma Inc.; has received funding for travel or speaker honoraria from Algorithm, Angelini, Astellas Pharma Inc., AstraZeneca, Cubist, Pfizer MSD, Gilead Sciences, Menarini, Novartis, Ranbaxy, and Teva. The other authors declare no conflict of interest.
: The study was approved by the Ethics Committees of the hospitals of the participating study sites and by the National Organization of Medicines of Greece (ExternalRef removed: registration number NCT00297674).
: Patients were enrolled after written consent provided by first-degree relatives.